BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Biomarin Pharmaceutical Inc's account receivable for the three months ended in Sep. 2016 was $216 Mil. Biomarin Pharmaceutical Inc's revenue for the three months ended in Sep. 2016 was $280 Mil. Hence, Biomarin Pharmaceutical Inc's days sales outstanding for the three months ended in Sep. 2016 was 70.38.
During the past 13 years, Biomarin Pharmaceutical Inc's highest Days Sales Outstanding was 86.70. The lowest was 50.96. And the median was 74.40.
Biomarin Pharmaceutical Inc's days sales outstanding increased from Sep. 2015 (65.06) to Sep. 2016 (70.38).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Biomarin Pharmaceutical Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2015 is calculated as
Biomarin Pharmaceutical Inc's Days Sales Outstanding for the quarter that ended in Sep. 2016 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Biomarin Pharmaceutical Inc Annual Data
Biomarin Pharmaceutical Inc Quarterly Data
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.